India to Mexico: Exemestane Export Trade Route
India has recorded 12 verified shipments of Exemestane exported to Mexico, representing a combined trade value of $446.1K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $37.2K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 85% of total export value with 5 shipments worth $379.1K USD. On the buying side, ALTERNAVIDA SA DE is the largest importer in Mexico with $309.4K USD in purchases. The top 3 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , ATLAS ENTERPRISES — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Mexico Exemestane corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $446.1K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's exemestane manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $37.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with exemestane's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 16.8%, placing it at rank #13 among India's top exemestane export destinations globally.
On the import side, key buyers of Indian exemestane in Mexico include ALTERNAVIDA SA DE, ALTERNAVIDA SA DE CV Y/O MOVERS SOL, GRADINTER S.C and 4 others. ALTERNAVIDA SA DE is the single largest importer with 2 shipments valued at $309.4K USD.
Route Characteristics
- Average transit19 days
